» Articles » PMID: 38541377

Barriers to Accessing and Engaging in HIV Preventive Care and Pre-Exposure Prophylaxis Experienced by Transgender Women in Florida

Abstract

Background: PrEP, a biomedical HIV prevention option, continues to be underutilized among transgender women who could benefit from sustained use, especially women of color and those who identify as Latina and/or reside in the southeastern US.

Objective: We explored the barriers and facilitators experienced by transgender women who live in Florida regarding accessing, using, and/or staying on PrEP.

Methods: In-depth interviews and focus groups were conducted in either Spanish or English with adult transgender women living in Florida (N = 22). The interviews were audio-recorded, transcribed, and coded in ATLAS.ti using thematic analyses.

Results: The mean age of the participants was 42.2 years. Among the participants, 73% were Hispanic/Latina, 59% were foreign-born, and approximately one-third were living with HIV (but had past experience with PrEP). Transgender women cited the following barriers to accessing or considering PrEP: (1) costs and benefits of PrEP use; (2) under-representation in clinical trials resulting in unknown or misinformation regarding PrEP side effects; (3) chronic poverty; and (4) trauma and discrimination. Other stressors, such as behavioral healthcare needs, were identified.

Conclusions: Our analysis revealed interlocking systems of oppression like transphobia, discrimination, and misgendering, which were common barriers experienced by our participants. These synergistically epidemic (i.e., syndemic) barriers contributed to their feelings of being systematically excluded in social spaces, research, public health planning and policies, laws, and social programs related to PrEP. These structural barriers are impediments to HIV preventive care but also act as a source of stress that contributes to mental health problems, financial vulnerability, substance abuse, and other deleterious health outcomes.

Citing Articles

Latin Transgender and Gender-Diverse Individuals' Perceptions of Well-Being During the COVID-19 Pandemic.

Peguero H, Stephens D, Duong J, Obee A Behav Sci (Basel). 2024; 14(11).

PMID: 39594297 PMC: 11591095. DOI: 10.3390/bs14110997.


Gender and Age Trends in HIV Incidence in Turkey between 1990 and 2021: Joinpoint and Age-Period-Cohort Analyses.

Derin O Medicina (Kaunas). 2024; 60(8).

PMID: 39202638 PMC: 11356638. DOI: 10.3390/medicina60081357.

References
1.
Perez-Brumer A, Reisner S, McLean S, Silva-Santisteban A, Huerta L, Mayer K . Leveraging social capital: multilevel stigma, associated HIV vulnerabilities, and social resilience strategies among transgender women in Lima, Peru. J Int AIDS Soc. 2017; 20(1):21462. PMC: 5467605. DOI: 10.7448/IAS.20.1.21462. View

2.
Sevelius J, Deutsch M, Grant R . The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016; 19(7(Suppl 6)):21105. PMC: 5071750. DOI: 10.7448/IAS.19.7.21105. View

3.
Cyrus E, Johnson S, Perez-Gilbe H, Wuyke G, Fajardo F, Garba N . Engagement in Care and Housing Instability Influence HIV Screening Among Transgender Individuals in South Florida. Transgend Health. 2022; 7(1):52-60. PMC: 8867217. DOI: 10.1089/trgh.2020.0066. View

4.
Poteat T, Wirtz A, Reisner S . Strategies for engaging transgender populations in HIV prevention and care. Curr Opin HIV AIDS. 2019; 14(5):393-400. DOI: 10.1097/COH.0000000000000563. View

5.
Escudero D, Bennett B, Suarez S, Darrow W, Mayer K, Seage 3rd G . Progress and Challenges in "Getting to Zero" New HIV Infections in Miami, Florida. J Int Assoc Provid AIDS Care. 2019; 18:2325958219852122. PMC: 6573019. DOI: 10.1177/2325958219852122. View